faqs.org » Abstracts Index » Abstracts » Business

Antiinfective biotechs face partnering gap

Article Abstract:

Biotech companies entering the antiinfective sector face an added difficulty in finding development and marketing partners due to a shift in the pharmaceutical groups' focus on antiinfectives. However, Vicuron, formed with the merger of US firm Versicor and Italian pharma spin-out Bio-Search Italia, has demonstrated that anti-infection companies could build a decent-market capitalization by combining robust late stage assets with an ability to implement their business plan.

Management dynamics, Alliances, partnerships, Management, Company business management, Alliances and partnerships, Vicuron Pharmaceuticals Inc.

---

A taste of the future

Article Abstract:

Senomyx has signed a clutch of licensing deals with large corporations to commercialize molecules generated through the discovery programme. Senomyx applies the high-throughput screening methods developed for drug discovery, to hunt for novel molecules that modulate the activity of taste receptors.

Contracts & orders received, Contracts & orders let, Contracts, Discovery and exploration, Contract agreement, Molecules, Senomyx Inc.

---

Some parts © 2012 Advameg, Inc.